AmCAD-UB : AI Solution for Breast Lesion Detection

AI-driven Diagnostics

Information

Key Features: * Color-coded Lesion Highlights Displays lesion traits like margin, texture, and echogenicity using proprietary visualization. * Built-in BI-RADS Lexicons Applies standardized BI-RADS terms for clear, consistent risk assessment and reporting.
AmCad BioMed CorporationS7.B98AmCad BioMed, founded in 2008 and listed on the Taipei Exchange (Ticker: 4188), specializes in AI-powered ultrasound solutions that support early and accurate diagnosis. We develop patented ultrasound AI technologies that help doctors detect diseases faster and interpret images with greater consistency. Headquartered in Taiwan, AmCad holds multiple FDA and CE certifications and continues to advance medical imaging through real-world innovation. We are committed to responsible growth, with strong investments in R&D and a focus on ESG principles across our operations.

Log in

See all the content and easy-to-use features by logging in or registering!